Showing results (1501-1510 of 2,361) with videos related to
Sort By:
Pageof 237
Clinical Neuropharmacology|October 1, 1993
Short-term memory in Parkinson's disease after withdrawal of long-term anticholinergic therapyG van Herwaarden, H J Berger, M W HorstinkClinical Neuropharmacology|February 1, 1994
L-dopa malabsorption in a parkinsonian patient with Strongyloides stercoralis duodenitisM Gatto, M Fernandez Pardal, M Melero, et al.Clinical Neuropharmacology|January 1, 1993
Serotonin receptor subtypes and affective disordersD S RobinsonClinical Neuropharmacology|October 1, 1992
Acetazolamide improves action myoclonus in Ramsay Hunt syndromeJ Vaamonde, I Legarda, J Jimenez-Jimenez, et al.Clinical Neuropharmacology|October 1, 1992
Naloxone or haloperidol but not yohimbine reverse apomorphine-induced respiratory depressionJ L Montastruc, O Rascol, P MontastrucClinical Neuropharmacology|October 22, 2005
Drug-induced psychosis in Parkinson disease: phenomenology and correlations among psychosis rating instrumentsKelvin L Chou, Susan Messing, David Oakes, et al.Clinical Neuropharmacology|May 1, 2002
Medical treatment of patients with infantile spasmsMohamad A Mikati, Garine A Lepejian, Gregory L HolmesClinical Neuropharmacology|May 1, 2002
Treatment of patients with tardive dystonia with olanzapineClaudio Lucetti, Giovanna Bellini, Angelo Nuti, et al.Clinical Neuropharmacology|May 1, 2002
Levodopa pharmacokinetics and motor performance during activities of daily living in patients with Parkinson's disease on individual drug combinationsDag Nyholm, Hans Lennernäs, Cecilia Gomes-Trolin, et al.Clinical Neuropharmacology|May 1, 2002
Amantadine sulfate infusion effect on N30 somatosensory evoked potentials in Parkinson's diseaseSevasti Bostantjopoulou, Zoe Katsarou, George Georgiadis, et al.Pageof 237